• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菲律宾精神分裂症患者迟发性运动障碍的现患率及相关因素。

The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.

机构信息

Department of Neurology and Psychiatry, University of Santo Tomas Hospital, Manila, Philippines.

出版信息

Parkinsonism Relat Disord. 2009 Nov;15(9):655-9. doi: 10.1016/j.parkreldis.2009.02.015. Epub 2009 Apr 5.

DOI:10.1016/j.parkreldis.2009.02.015
PMID:19346155
Abstract

OBJECTIVE

To determine the prevalence of and the factors associated with tardive dyskinesia (TD) among Filipino patients with schizophrenia admitted at the National Center for Mental Health.

STUDY DESIGN

Cross-sectional study.

METHODS

A total of 227 inpatients fulfilling the DSM-IV TR criteria for schizophrenia participated in the study. Demographic data including age, disease duration and medication intake were obtained. The Abnormal Involuntary Movement Scale (AIMS) and Simpson Angus Rating Scale (SARS) were performed on all patients. Odds of developing TD in relation to the different variables were computed. The association between study variables and development of TD was also evaluated using the Chi-square test.

FINDINGS

Our cohort of patients had a mean age of 40 (range: 19-73 years old), had a mean disease duration of 6 years, had a daily neuroleptic dose of 700 mg in chlorpromazine equivalent, and had a lifetime neuroleptic exposure of at least 5 years. The prevalence rate of TD was 20.3% (46 out of 227 patients). Fifty-three percent of patients had significant extrapyramidal features (SARS > or =3). TD was noted more in females and older age groups. The other factors associated with TD: were those patients with longer duration of illness and those patients with longer cumulative exposure to neuroleptic drugs. There was no association found with regard to the presence of diabetes mellitus type II, to the use of anticholinergic drugs, to the history of substance abuse and to the history of electroconvulsive therapy.

CONCLUSIONS

Despite the predominant use of first-generation antipsychotic agents, the prevalence of TD among Filipino schizophrenic patients is similar to that reported among Asians, but lower than that reported among our Western counterparts. The results may be affected by differences in methodological, racial and genetic determinants.

摘要

目的

在菲律宾国家心理健康中心,确定精神分裂症住院患者中迟发性运动障碍(TD)的流行情况及其相关因素。

研究设计

横断面研究。

方法

共有 227 名符合 DSM-IV-TR 精神分裂症标准的住院患者参与了本研究。获得了人口统计学数据,包括年龄、疾病持续时间和药物摄入。对所有患者进行了异常不自主运动量表(AIMS)和辛普森 Angus评定量表(SARS)检查。计算了出现 TD 的几率与不同变量之间的关系。使用卡方检验评估研究变量与 TD 发展之间的关系。

结果

我们的患者队列平均年龄为 40 岁(范围:19-73 岁),平均病程为 6 年,每日接受相当于氯丙嗪 700mg 的神经阻滞剂治疗,且终生至少接受了 5 年的神经阻滞剂治疗。TD 的患病率为 20.3%(227 例患者中有 46 例)。53%的患者有明显的锥体外系症状(SARS≥3)。TD 更常见于女性和年龄较大的患者。与 TD 相关的其他因素是:病程较长和累积暴露于神经阻滞剂药物时间较长的患者。未发现与 2 型糖尿病、使用抗胆碱能药物、药物滥用史和电惊厥治疗史有关。

结论

尽管主要使用第一代抗精神病药物,但菲律宾精神分裂症患者的 TD 患病率与亚洲报道的患病率相似,但低于西方报道的患病率。结果可能受到方法学、种族和遗传决定因素的差异影响。

相似文献

1
The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.菲律宾精神分裂症患者迟发性运动障碍的现患率及相关因素。
Parkinsonism Relat Disord. 2009 Nov;15(9):655-9. doi: 10.1016/j.parkreldis.2009.02.015. Epub 2009 Apr 5.
2
Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.氯氮平致精神分裂症患者服用氯氮平作为一线抗精神病药物后迟发性运动障碍。
World J Biol Psychiatry. 2009;10(4 Pt 3):919-24. doi: 10.1080/15622970802481895.
3
Tardive dyskinesia and impaired glucose tolerance.迟发性运动障碍与葡萄糖耐量受损。
Hum Psychopharmacol. 2002 Aug;17(6):305-7. doi: 10.1002/hup.413.
4
Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.中国精神分裂症患者中CYP2D6和CYP1A2基因多态性与迟发性运动障碍的关联
Acta Pharmacol Sin. 2006 Mar;27(3):328-32. doi: 10.1111/j.1745-7254.2006.00279.x.
5
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.比哌立登与金刚烷胺对帕金森氏症和迟发性运动障碍型不自主运动的疗效无差异:一项针对药物治疗的慢性精神分裂症患者的双盲交叉、安慰剂对照研究。
J Clin Psychiatry. 1995 Apr;56(4):167-70.
6
Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.物质滥用作为迟发性运动障碍的一个风险因素:对1027例患者的回顾性分析。
Psychopharmacol Bull. 1997;33(1):177-81.
7
CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.精神分裂症患者的CYP2D6基因多态性与迟发性运动障碍
Pharmacopsychiatry. 2003 Mar-Apr;36(2):73-8. doi: 10.1055/s-2003-39048.
8
A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.锂盐治疗的情感障碍患者中帕金森综合征和迟发性运动障碍的横断面研究。
J Clin Psychiatry. 1996 Jan;57(1):22-8.
9
Tardive dyskinesia in India: a prevalence study.印度的迟发性运动障碍:一项患病率研究。
J Clin Psychopharmacol. 1982 Oct;2(5):341-4.
10
Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia.病例系列:儿童期起病精神分裂症中抗精神病药物所致运动障碍及锥体外系副作用的范围
J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):221-7. doi: 10.1097/00004583-199802000-00016.

引用本文的文献

1
Predictors of extrapyramidal side effects among patients taking antipsychotic medication at Mekelle psychiatry units, Northern Ethiopia, 2023: unmatched case-control study.2023年埃塞俄比亚北部默克莱精神病科服用抗精神病药物患者锥体外系副作用的预测因素:非匹配病例对照研究
BMC Psychiatry. 2025 Aug 28;25(1):837. doi: 10.1186/s12888-025-07202-7.
2
Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.亚洲的迟发性运动障碍——当前临床实践及神经科医生在护理流程中的作用
Front Neurol. 2024 Feb 14;15:1356761. doi: 10.3389/fneur.2024.1356761. eCollection 2024.
3
Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia.
埃塞俄比亚东部公立医院就诊患者的药物性运动障碍及其相关因素
Neuropsychiatr Dis Treat. 2020 Aug 17;16:1987-1995. doi: 10.2147/NDT.S261272. eCollection 2020.
4
Assesment of Risk Factors for Tardive Dyskinesia.评估迟发性运动障碍的风险因素。
Psychopharmacol Bull. 2020 Jul 23;50(3):36-46.
5
Analysis of risk factors and outcomes in psychiatric inpatients with tardive dyskinesia: A nationwide case-control study.迟发性运动障碍精神科住院患者的危险因素及结局分析:一项全国性病例对照研究。
Heliyon. 2019 May 17;5(5):e01745. doi: 10.1016/j.heliyon.2019.e01745. eCollection 2019 May.
6
Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.抗精神病药物所致锥体外系症状的危险因素及其与精神分裂症症状的相关性研究
Gen Psychiatr. 2019 Feb 23;32(1):e100026. doi: 10.1136/gpsych-2018-100026. eCollection 2019.
7
Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study.埃塞俄比亚中部安曼尼精神专科医院的精神分裂症患者第一代抗精神病药物引起的副作用的流行情况和管理做法:横断面研究。
BMC Psychiatry. 2019 Jan 18;19(1):32. doi: 10.1186/s12888-018-1999-x.
8
Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis.一种用于精神疾病中运动障碍的护士执行筛查工具的开发与临床测量评估
BJPsych Open. 2018 Sep 27;4(5):404-410. doi: 10.1192/bjo.2018.55. eCollection 2018 Sep.
9
A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.慢性精神分裂症患者迟发性运动障碍特征的横断面研究
Shanghai Arch Psychiatry. 2017 Oct 25;29(5):295-303. doi: 10.11919/j.issn.1002-0829.217008.
10
Medication-Induced Tardive Dyskinesia: A Review and Update.药物性迟发性运动障碍:综述与更新
Ochsner J. 2017 Summer;17(2):162-174.